Edwards Lifesciences Corporation (EW)
NYSE · Healthcare
Edwards Lifesciences Corporation Long Term Debt 2008–2025
Edwards Lifesciences Corporation annual long term debt history from 2009 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Edwards Lifesciences Corporation long term debt as of December 31, 2025: 598.3M, a 0.10% increase year-over-year.
- Edwards Lifesciences Corporation long term debt for 2025 were 598.3M, a 0.10% increase from 2024.
- Edwards Lifesciences Corporation long term debt for 2024 were 597.7M, a 0.12% increase from 2023.
- Edwards Lifesciences Corporation long term debt for 2023 were 597.0M, a 0.12% increase from 2022.
- Edwards Lifesciences Corporation long term debt for 2022 were 596.3M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Edwards Lifesciences Corporation Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $598 |
| 2024 | $598 |
| 2023 | $597 |
| 2022 | $596 |
| 2021 | $596 |
| 2020 | $595 |
| 2019 | $594 |
| 2018 | $594 |
| 2017 | $438 |
| 2016 | $822 |
| 2015 | $597 |
| 2014 | $598 |
| 2013 | $600 |
| 2012 | $189 |
| 2009 | $90 |
Edwards Lifesciences Corporation Long Term Debt — FAQ
Edwards Lifesciences Corporation (EW) long term debt over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see EW's long term debt history?
The chart and table above show Edwards Lifesciences Corporation's long term debt by year and by quarter, including the growth rate.